• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

November 8, 2019
Company Drug/Device Medical Condition Status
BioCryst Pharmaceuticals, Inc. BCX9250 fibrodysplasia ossificans progressive (FOP) Phase 1 trial initiated enrolling healthy subjects
Revolution Medicines, Inc.

Amgen
RMC-4630 in combination with AMG 510 advanced solid tumors Phase 1b trial initiated enrolling subjects with advanced solid tumors harboring the KRASG12C mutation
X4 Pharmaceuticals, Inc. X4P-001 Severe Congenital Neutropenia (SCN) Phase 1b trial initiated enrolling 45 subjects with SCN and other selected congenital neutropenia disorders
CohBar, Inc. CB4211 nonalcoholic steatohepatitis (NASH), NAFLD and obesity Phase 1b trial initiated enrolling 20 obese subjects with NAFLD
Cartesian Therapeutics Descartes-08 generalized myasthenia gravis (GMG) Phase 1/2 trial initiated
Ichnos Sciences ISC 27864 osteoarthritic pain Phase 2b trial initiated enrolling 624 adult subjects with moderate osteoarthritic pain of the knee and/or hip at sites in India.
Ichnos Sciences ISB 830 atopic dermatitis Phase 2b trial initiated enrolling 312 adult subjects with moderate to severe atopic dermatitis at sites in the U.S., Canada and Europe
RhoVac AB RV001 prostate cancer Phase 2b trial initiated enrolling 175 subjects at multiple centers in Denmark, Finland, Sweden, United Kingdom, Belgium, Germany and the U.S.
Biohaven Pharma Holding Company Ltd. troriluzole Alzheimer’s disease Phase 2/3 trial initiated enrolling subjects with mild to moderate Alzheimer’s disease
CymaBay Therapeutics, Inc. seladelpar Primary Biliary Cholangitis (PBC) Phase 3 trial initiated enrolling 240 subjects in over 20 countries
Revance Therapeutics, Inc. DaxibotulinumtoxinA for Injection (DAXI) isolated cervical dystonia (CD) Phase 3 trial initiated enrolling 301 subjects at 60 sites in the U.S., Canada and Europe
EpicentRX, Inc. RRx-001 small cell lung cancer Phase 3 trial initiated enrolling 126 subjects with third-line and beyond small cell lung cancer
Okami Medical Inc. LOBO Vascular Occlusion System occlusion of peripheral blood vessels 510(k) approval granted by the FDA
Autolus Therapeutics plc AUTO1 acute lymphoblastic leukemia (ALL) Orphan drug designation granted by the FDA
Sanofi Fluzone High-Dose Quadrivalent (Influenza Vaccine) prevention of influenza disease caused by influenza A and B strains contained in the vaccine in subjects 65 years of age and older sBLA approval granted by the FDA
RedHill Biopharma Ltd. Talicia (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg1/250 mg/12.5 mg Helicobacter pylori (H. pylori) infection in adults Approval granted by the FDA
GE Healthcare Clariscan intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity Approval granted by the FDA
Crescita Therapeutics Inc. Pliaglis (enhanced formulation) superficial dermatological procedures Approval granted by the FDA
Sandoz Ziextenzo (pegfilgrastim) infection in cancer patients Approval granted by the FDA

 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing